India-first coverage of semaglutide, GLP-1 drugs, and obesity treatment — aggregated daily from across the web.
Local Roundup: Gujarat Passes Uniform Civil Code, Generic Semaglutide Hits Indian Pharmacies, and Arundhati Roy Wins US Book Critics Award Local Samosa
Ozempoc & Semaglutide: Transforming Metabolic Treatment Microbioz India
Free Market Ozempic Will Make A Huge Difference To Tens Of Millions Of People – OpEd Eurasia Review
Indian pharma is ready to flex generics muscle as Ozempic, Wegovy patent expires today MSN
Semaglutide side effects: Is it safe? What you need to know AOL.com
Telangana DCA issues safety advisory on use of semaglutide Pharmabiz.com
Starting a GLP-1? Doctors Reveal Surprising Benefits and Side Effects To Watch For Woman's World
Python blood could help make the next big weight loss drug — without GLP-1 side effects New York Post
Oral GLP-1s, COVID preventatives: 3 more drugs in the pipeline, Optum says payers should watch Fierce Healthcare
Higher dose semaglutide gets fast FDA nod amid patent pressure Longevity.Technology
FDA Crackdown Puts Pressure on GLP-1 Compounders, Telehealth Providers Law.com
FDA’s enforcement and compounded drugs: The GLP-1 test case The Pharma Letter
Ozempic vs Olymviq: Why Novo Nordisk sued India’s Dr Reddy’s over weight loss product trademark The Indian Express
Novo Nordisk's Pipeline Successor Outperforms Flagship Weight-Loss Drug AD HOC NEWS
Fierce Pharma Asia—Takeda’s $1.3B reorg; India’s GLP-1 floodgates; Gilead’s $2.2B buy of a China NewCo Fierce Pharma
China-developed triple incretin enters global diabetes race BioWorld MedTech
News articles are aggregated from third-party RSS feeds. GLP-1 Check does not endorse or verify individual articles. Content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any treatment.
